6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
1m ago	Global Leaders to Discuss Water Positivity at Sustainability LIVE Leadership Summit at London Climate Action Week
1m ago	Combined General Meeting of May 22, 2026
2m ago	Cuprina Holdings announces 1-for-8 Share Consolidation
2m ago	La Roche-Posay Announces Its Partnership Renewal with Keke Palmer As The Face Of Its Mela B3 Franchise Expansion
3m ago	SemiLux International Ltd. Announces Receipt of Nasdaq Staff Determination Letter and Intention to Request Hearing

About

810.00TWD+12.00 +1.50%

Closed • Updated at 15:03 GMT+00:00

Market Cap$9.34B

P/E Ratio50.73

Volume1.34M

Beta0.66

RSI70.36

Gross Margin87.29%

Health TechnologyPharmaceuticals: Major

Pharmaessentia Corp. — investor relations, events, news, and company updates on 6ix.

Latest News

PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026

Taiwan's Representative to the United States Alexander Tah-ray Yui Visits PharmaEssentia's Puerto Rico Facility Alongside Puerto Rico Officials

Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health

PharmaEssentia Signs Investment Agreement for New Manufacturing Facility in Puerto Rico

PharmaEssentia Announces Japan Approval of High-Dose Dosing Regimen for BESREMi®

Community Chat

Ask AI